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Abstract
Enterotoxigenic Escherichia coli (ETEC) cause severe diarrhoea in humans and neonatal farm animals. Annually, 380,000
human deaths, and multi-million dollar losses in the farming industry, can be attributed to ETEC infections. Illness results
from the action of enterotoxins, which disrupt signalling pathways that manage water and electrolyte homeostasis in the
mammalian gut. The resulting fluid loss is treated by oral rehydration. Hence, aqueous solutions of glucose and salt are
ingested by the patient. Given the central role of enterotoxins in disease, we have characterised the regulatory trigger that
controls toxin production. We show that, at the molecular level, the trigger is comprised of two gene regulatory proteins,
CRP and H-NS. Strikingly, this renders toxin expression sensitive to both conditions encountered on host cell attachment
and the components of oral rehydration therapy. For example, enterotoxin expression is induced by salt in an H-NS
dependent manner. Furthermore, depending on the toxin gene, expression is activated or repressed by glucose. The precise
sensitivity of the regulatory trigger to glucose differs because of variations in the regulatory setup for each toxin encoding
gene.
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Introduction
ETEC are Gram negative bacteria that cause severe diarrhoea,
known as non-vibrio cholera, in humans [1,2]. First isolated in
1971, ETEC are responsible for 210 million infections annually,
mostly in developing countries, leading to 380,000 deaths [3].
Disease results primarily from the action of two enterotoxins. The
heat-labile toxin (LT) is similar in structure and function to cholera
toxin [4,5]. The heat-stable toxin (ST) mimics the human
hormone guanylin [6]. Both toxins are secreted by ETEC during
infection. Made up of two subunits, encoded by the eltAB operon,
LT has the configuration AB5 [5,7]. In the gut, LT binds to host
cell GM1 gangliosides and is endocytosed [8,9]. This triggers
constitutive cAMP production in the affected cell [8]. The ST
toxin, encoded by the estA gene, also interferes with cell signalling
[6]. Hence, ST binds to the guanylate cyclase C receptor and
stimulates overproduction of cGMP. The combined actions of LT
and ST cause loss of H2O, and electrolytes, from epithelial cells
into the gut lumen [4]. Oral Rehydration Therapy (ORT) is used
to redress the resulting electrolyte imbalance and rehydrate the
patient [10]. In its most simple form, ORT requires only an
aqueous solution of glucose and salt. Hence, the availability of
metabolites and cations are a central theme of ETEC mediated
disease. The effect of ORT on human physiology is well
understood: glucose and Na2
+ are transported across the epithelial
membrane, along with water, to promote rehydration [11].
Surprisingly, despite the existence of molecular mechanisms that
allow bacteria to respond to these signals, the consequences for
ETEC are unknown.
In E. coli, the transcriptional response to glucose is controlled by
cAMP receptor protein (CRP) [12]. In the absence of glucose,
intracellular cAMP levels increase and CRP binds DNA targets
with the consensus sequence 59-TGTGA-n6-TCACA-39 [13].
Subsequently, gene expression is reprogrammed to make use of
alternative carbon sources [14]. Note that the gene regulatory
network managed by CRP includes many indirect pathways
[14,15]. Hence, CRP is also a pleiotropic regulator of transcrip-
tion. Whilst indirect regulatory effects are difficult to characterise,
genes that are directly controlled by CRP can be divided into
distinct classes [12]. At Class II targets, CRP binds to a site
overlapping the promoter -35 element and interacts directly with
both the N-terminal and C-terminal domains of the RNA
polymerase a subunit (aNTD and aCTD). At Class I targets,
CRP binds further upstream and interacts only with aCTD. This
interaction can be further stabilised by UP-elements, AT-rich
DNA sequences, adjacent to the CRP site, that facilitate aCTD-
DNA interactions [12]. At both classes of promoter, the various
contacts enhance gene expression by stabilising the transcription
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initiation complex. Unsurprisingly, most genes regulated by CRP
encode proteins involved in metabolism. However, in some
bacteria, CRP has been co-opted as a virulence regulator [16].
The Histone-like Nucleoid Structuring (H-NS) factor is a
component of bacterial nucleoprotein. Consequently, H-NS also
influences gene expression on a global scale [17]. Briefly, H-NS
targets sections of the genome with a low GC content [17].
Depending on H-NS conformation, the resulting nucleoprotein
complexes can be filamentous or bridged in organisation [18].
Filamentous complexes favour gene regulation by excluding RNA
polymerase, and transcriptional regulators, from their targets
[19,20]. Bridged complexes favour RNA polymerase trapping
[21]. In all scenarios, it is thought that H-NS acts primarily to
silence transcription [22]. The conformation of H-NS, and hence
the way in which it modulates DNA topology, can be controlled by
divalent cations. Consequently, H-NS mediated repression can be
relieved by increased osmolarity [23]. Like CRP, H-NS has been
incorporated into the virulence gene regulatory networks of many
bacteria [17].
In this work we define the molecular trigger that controls toxin
expression in ETEC. We show that CRP and H-NS are key
regulatory factors. Strikingly, this allows ETEC to integrate
extracellular signals of osmolarity and metabolism to control toxin
production. Hence, we propose that ETEC toxicity responds
directly to osmo-metabolic flux. Interestingly, the precise regula-
tory settings are different for each toxin encoding gene. The
differences result from i) varying promoter configurations and ii)
competition between CRP and H-NS for overlapping DNA
targets. This is significant since fluctuations in osmolarity, and
changes in the availability of metabolites, are central to ETEC
infection and its treatment.
Results
Binding of CRP and H-NS across the ETEC H10407
genome
The prototypical ETEC strain H10407 reproducibly elicits
diarrhoea in human volunteers and has a well-defined genome
that shares 3,766 genes with E. coli K-12 [1]. Pathogenicity arises
from 599 ancillary genes encoded by 25 discrete chromosomal loci
and 4 plasmids. The plasmids, named p948, p666, p58 and p52,
encode the enterotoxins. Derivatives of the estA gene are found on
plasmids p666 (estA1) and p948 (estA2). A single copy of the eltAB
operon is encoded by plasmid p666. We used Chromatin
Immunoprecipitation (ChIP) coupled with next-generation DNA
sequencing (ChIP-seq) to map CRP and H-NS targets across the
ETEC H10407 genome. The binding profiles are shown in
Fig. 1A. In each plot genes are illustrated by blue lines (tracks 1
and 2), DNA G/C content by a cyan and pink graph (track 3), H-
NS binding is in green (track 4) and CRP binding is shown in
orange (track 5). As expected, H-NS binding is inversely correlated
with DNA G/C content (compare tracks 3 and 4). Similarly, CRP
binding occurs in expected locations; 96% of the CRP binding
sites are associated with the DNA logo shown in Fig. 1B (i.e. the
known CRP consensus sequence (13–15)). We identified a total of
111 high-confidence CRP targets (Table 1). Of these targets 93%
were present in the genome sequences of both ETEC H10407 and
E. coli K-12. The most common location for CRP sites was in
intergenic regions (66% of targets) whilst a smaller number of
targets were found within genes (34%). Consistent with expecta-
tions, CRP sites were most frequently located ,40.5 bp, or
,92.5 bp, upstream of experimentally determined transcription
start sites (TSSs). Surprisingly, CRP binding was restricted to the
ETEC chromosome (Fig. 1Ai). Conversely, H-NS bound to
chromosomal and plasmid loci (Fig. 1Ai), including all toxin
encoding genes (Fig. 1Aii).
Unoccupied high-affinity CRP binding targets on p948
and p666 are bound by H-NS
To better understand the lack of CRP binding to p948 and
p666 we took a bioinformatic approach. CRP targets were aligned
to generate a position weight matrix (PWM). The PWM was then
used to search p948 and p666 for CRP sites. A continuum of over
100 potential CRP targets was identified. However, we recognise
that the vast majority of these are likely to be false positives.
Hence, we next sought to differentiate between genuine CRP sites
and spurious predictions. To do this, predicted sites were scored,
grouped, and ranked on the basis of their match to the PWM
(Fig. 2A, S1 Table). Electrophoretic mobility shift assays (EMSA)
were then used to measure binding of CRP to a target from each
group so that a meaningful cut-off could be established. The result
is illustrated graphically in Fig. 2B. The raw data are shown in
S1A Fig. We found that predicted sites with a score,10 did not
bind CRP. To assess the affinity of CRP for all predicted targets
scoring .10 a second set of EMSA experiments was done (S1B
Fig.). Hence, we identified a total of 5 potential CRP targets on
p666 and p948. Interestingly, the estA1 and estA2 genes, which
both encode ST, were amongst the 5 targets (Fig. 2C). Remark-
ably, all 5 of the plasmid borne CRP targets identified in silico,
and bound tightly by CRP in vitro, were occupied by H-NS in
vivo (Fig. 2C).
The estA2 gene is transcribed from a Class I CRP
dependent promoter
To understand if CRP could regulate ST production we focused
first on estA2. This derivative of the toxin is more commonly
associated with human disease and ETEC H10407 is somewhat
unusual in also encoding estA1 [24]. The sequence of the estA2
regulatory region is shown in Fig. 3A. A 93 bp DNA fragment,
containing the regulatory region, was cloned into the lacZ reporter
plasmid pRW50 to generate a lacZ fusion (S2A Fig.). The estA2
TSS was then determined using mRNA primer extension analysis.
We detected a single extension product, of 109 nucleotides (nt) in
length (Fig. 3B). The position of the TSS is labelled ‘‘+1’’ in
Fig. 3A. Promoter -10 (59-TTAAAT-39) and -35 (59-TTGCGC-
39) elements were observed at the expected positions upstream of
the TSS. Throughout this work we refer to this promoter,
highlighted purple in Fig. 3A, as PestA2. To confirm CRP binding
Author Summary
Diarrheagenic illness remains a major disease burden in
the developing world. Enterotoxigenic Escherichia coli
(ETEC) are the leading bacterial cause of such disease;
hundreds of millions of cases occur every year. The severe
watery diarrhoea associated with ETEC infections results
from the action of enterotoxins. The toxins target human
gut epithelial cells and trigger the loss of water and
electrolytes into the gut lumen. Oral rehydration therapy
can counteract this process. Hence, glucose and salt
solutions promote rehydration of the patient. In this work
we show that the gene regulatory mechanisms controlling
toxin expression respond directly to sugar and salt.
Furthermore, we describe a molecular mechanism to
explain these effects. Hence, we provide a starting point
for the optimisation of oral rehydration solutions to reduce
toxin expression over the course of an ETEC infection.
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at the predicted site we used DNase I footprinting (Fig. 3C). As
expected, CRP protected the predicted target from digestion.
Additionally, CRP induced DNase I hypersensitivity in the centre
of the site. Note that the CRP site is centred 59.5 bp upstream of
the TSS and adjacent to an AT-rich sequence that may be an UP
element (Fig. 3A). Thus, we hypothesised that PestA2 is a class I
CRP activated promoter. To test our hypothesis we first
determined whether CRP could indeed activate PestA2. To
do this, we compared LacZ expression in M182Dlac and
M182DlacDcrp cells carrying the PestA2::lacZ fusion. The data
show that loss of CRP results in a 3-fold decrease in LacZ
expression from PestA2 (Fig. 3D). We next tested the ability of
CRP to activate PestA2 in vitro. The 93 bp DNA fragment was
cloned upstream of the loop terminator in plasmid pSR. In the
context of this construct a 112 nt transcript is generated by RNA
polymerase from PestA2 in vitro. The amount of transcript can
then be quantified by electrophoresis. The result of the analysis,
with and without CRP, is shown in Fig. 3E. As expected, an
intense band corresponding to the 112 nt transcript was observed.
Production of the transcript was stimulated by CRP. Note that
CRP had no effect on production of the 108 nt control RNAI
transcript from the plasmid replication origin. Finally, we
examined the AT-rich DNA sequence (highlighted blue in
Fig. 3A) located between the CRP site and the promoter -35
element. We found that increasing the GC content of the putative
UP-element altered migration of the 93 bp DNA fragment on an
agarose gel, consistent with a change in DNA topology (S3A Fig.).
Moreover, these changes to the UP-element rendered PestA2
insensitive to CRP in vivo and in vitro (S3B Fig.).
H-NS excludes CRP from the estA2 promoter and
represses estA2 transcription
Promoters can be liberated from H-NS repression if separated
from flanking, H-NS bound, DNA [25]. We reasoned that this
Fig. 1. Distribution of CRP and H-NS across the ETEC H10407 genome. A) The panel shows maps of the ETEC H10407 chromosome (i) and
associated plasmids (ii). In each plot, tracks 1 and 2 (blue lines) show the position of genes, track 3 (purple and cyan graph) is a plot of DNA GC
content, track 4 (green) is the H-NS binding profile and track 5 (orange) is the CRP binding profile. B) A DNA sequence motif generated by aligning
regions of the ETEC H10407 chromosome bound by CRP.
doi:10.1371/journal.ppat.1004605.g001
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Table 1. High-confidence CRP binding sites on the ETEC H10407 chromosome identified by ChIP-seq.
Peak Centrea Binding Site(s)b Gene(s)c K-12 Homologuesd
45284 TGTGATTGGTATCACA ETEC_0040 caiT
92014 AGTGATGGATGTCACG (ETEC_0078) (cra)
176905 AGCGTTCCACGTCACA (ETEC_0150) (hemL)
408885 TGTGATCTCTCTCGCA ETEC_0385/ETEC_0386 yahN/yahO
461874 TGTGCGCAAGATCACA ETEC_0434 ddlA
463095 TTTGCGCGAGGTCACA (ETEC_0436) (phoA)
468009 AGGGATCTGCGTCACA ETEC_0443 aroM
492973 ATCGATTGCGTTCACG ETEC_0464 tsx
540805 TGTGATCTTTATCACA ETEC_0511 maa
574230 GATGACGACGATCACA (ETEC_0538) (ybaT)
683187 AGTGATCGAGTTAACA ETEC_0628 cstA
697540 AGTGATTTGCGTCACA ETEC_0639 rnk
739223 CGTTACCCTTGTCGCA ETEC_0680 rihA
941002 TGTGATGAGTATCACG ETEC_0869 ybiJ
958866 TGTGTACGAAATCACA ETEC_0886/ETEC_0887 ybiS/ybiT
1128472 n.d. (ETEC_1030) (yccS)
1205350 AGTGATGTAGATCACA ETEC_1101 ycgZ
TGAGATCGAGCACACA
1263558 TTTGACGGCTATCACG ETEC_1166 ptsG
1274886 TGTGATCTGGATCACA ETEC_1176/ETEC_1177 ycfQ/bhsA
1301786 GATGATCCGCATCACA (ETEC_1206)/ETEC_1207 ETEC-specific/ETEC-specific
1348166 ATTGAACAGGATCACA (ETEC_1259)/ETEC_1260 (rluE)/icd
1376374 GGTGAGCTGGCTCACA ETEC_1292/ETEC_1293 ycgB/dadA
1388620 AGTGAGCCAGTTAACA (ETEC_1303) (dhal)
1541732 CGTGAACCGGGTCACA ETEC_1443/ETEC_1444 ycjZ/mppA
1567885 GTTAAGTAAAATCACA ETEC_1462/ETEC_1463 paaZ/paaA
1701402 TGTGATGGATGTCACT ETEC_1568 ydeN
1767726 TGTGATTAACAGCACA ETEC_1628 mlc
1777143 TGTGATCTAGCGCCAA ETEC_1637 pntA
1811426 CGTGATCAAGATCACG (ETEC_1668A) (ETEC specific)
1859265 ATTGAGCGGGATCACA (ETEC_1713) (sufS)
1887513 AGTGATGCGCATCACG ETEC_1737 aroH
TGCGAGGTGTGTCACA
2126754 TGTGGCGTGCATCACA n.a. n.a.
2201816 GGTGACGCGCGTCACA ETEC_2057 yedP
2210222 CGTGATCTCGCGCACA ETEC_2065/ETEC_2066 yedR/ETEC-specific
2458348 TGTGATCTGAATCTCA ETEC_2278 cdd
TGCGATGCGTCGCGCA
2492757 ATTGATCGCCCTCACA ETEC_2309 yeiQ
2555083 CGTGACCAAAGTCTCA (ETEC_2360) (yfaQ)
2729713 TTTGAAGCTTGTCACA ETEC_2510/ETEC_2511 mntH/nupC
2735124 AGTTATTCATGTCACG ETEC_2514 yfeC
2795423 TGTGAGCCATGACACA (ETEC_2572)/ETEC_2573 (aegA)/narQ
2810983 CGTGATCAAGATCACA ETEC_2586 hyfA
2887131 TTTGATCTCGCTCACA (ETEC_2666)/ETEC_2665 (xseA)/guaB
3012645 TGTGATCCCCACAACA (ETEC_2793) (ung)
The Molecular Basis for Control of ETEC Enterotoxin Expression
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Table 1. Cont.
Peak Centrea Binding Site(s)b Gene(s)c K-12 Homologuesd
3048307 TTTGACGAGCATCACC (ETEC_2822) (emrB)
3132920 GGTGACCGGTTTCACA ETEC_2905/ETEC_2906 ascG/ascF
3161660 TGTGACCGTGGTCGCA (ETEC_2933) (nlpD)
3184337 CGTGATGCGTGTAACA (ETEC_2956)/ETEC_2955 (cysI)/cysH
3196088 TGTGATTACGATCACA ETEC_2966/ETEC_2967 ygcW/yqcE
3223792 AGTGATCTTGATCTCA ETEC_2986 sdaC
AGTTATGTATCTATCA
3234980 TGCGATCGTTATCACA (ETEC_2994)/ETEC_2995 (fucU)/fucR
3265047 TGTGACCTGGGTCACG ETEC_3017 rppH
3324543 TGTGGGCTACGTAACA (ETEC_3075) (ydhD)
3361162 n.d. ETEC_3105 serA
3368992 TTTGATGCACCGCACA (ETEC_3113) (ygfI)
3382158 TGTGATCTACAACACG ETEC_3126 cmtB
3390811 TGTGATTTGCTTCACA ETEC_3133 galP
3408173 TGTGATGTGGATAACA ETEC_3154 nupG
3442697 TGTGATGATTGTCGCA ETEC_3186 ETEC-specific
3558573 AGTGATTTGGCTCACA ETEC_3291 ygiS
3580767 AGTGACTTGCATCACA (ETEC_3318) (yqiH)
3635301 ATTGATCTAACTCACG ETEC_3362 uxaC
3642302 CTTGAAGTGGGTCACA (ETEC_3372) (yqjG)
3665634 TGTGATCAATGTCAAT ETEC_3393/ETEC_3394 garP/garD
TGTGCTTTAGCGCGCA
3721308 GGTGATTGATGTCACC (ETEC_3446) (greA)
3785700 CGTGGGTCGCATCACA (ETEC_3510) (mreC)
3878729 GGTGATTTTGATCACG ETEC_3614/ETEC_3615 ppiA/tsgA
3908574 GGTGATCGCGCTCACA (ETEC_3645) (hofM)
3918861 TGTGAGTGGAATCGCA ETEC_3652/ETEC_3653 yhgE/pck
3986400 CGTGATTTTATCCACA ETEC_3707 rpoH
4105040 AGTAAGGCAAGTCCCT n.a. n.a.
4111116 TGTGACGGGGCTAACA (ETEC_3806) (wecH)
4153055 TGTGATCTGAATCACA ETEC_3840 yibI
TGTGATCTACAGCATG
4153191 TGTGATTGATATCACA ETEC_3841 mtlA
TGTGATGAACGTCACG
4158433 n.d. ETEC_3846 lldP
4196869 TGCAATCGATATCACA ETEC_3886 dinD
4251326 CTTACTCCTGCTCACA ETEC_3938 ETEC specific
4266125 GGTGATGGCATCCGCG (ETEC_3956) (nepI)
4290730 GGTGAGCAAAACCACG (ETEC_3979) (yidR)
4322430 ATTGACCTGAGTCACA (ETEC_4010) (yieL)
4340544 CTTGACCACGGTCAGA (ETEC_4025)/ETEC_4024 (atpA)/atpG
4344649 TGTGATCTGAAGCACG ETEC_4030 atpI
4373517 TGTAATGCTGGTAACA (ETEC_4051) (ilvG)
4402013 CGTGCTGCATATCACG (ETEC_4077) (rffM)
4412999 CGTGATCAATTTAACA ETEC_4085/ETEC_4085 hemC/cyaA
4438352 GGTGATGAGTATCACG ETEC_4107/ETEC_4108 ysgA/udp
The Molecular Basis for Control of ETEC Enterotoxin Expression
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might be why, when isolated on the 93 bp fragment, PestA2 was
active and dependent on CRP. To test this logic we generated a
further two PestA2::lacZ fusions using the pRW50 plasmid system.
The additional PestA2 DNA fragments were both 460 bp in length
and include the full estA2 gene that was entirely bound by H-NS
in our ChIP-seq assay (Fig. 2C). The CRP site was ablated in one
of the additional fragments by introducing point mutations that
are predicted to disrupt CRP binding. The sequence of the DNA
fragments is shown in S2A Fig. The lacZ fusions are illustrated
graphically in Fig. 4A. Our expectation was that the longer
460 bp fragment would bind H-NS whilst the starting 93 bp
fragment would not. To test this prediction we used ChIP. Thus,
we compared H-NS binding to the different PestA2 containing
fragments in vivo. Fig. 4B shows results of a PCR analysis to
measure enrichment of the PestA2 locus. As expected, PestA2 was
only enriched in anti-H-NS immunoprecipitates when in the
context of the 460 bp fragment. Crucially, enrichment is specific
because, in a set of control PCR reactions, there was no
enrichment of the yabN locus in any immunoprecipitate.
Our ChIP analysis suggests that the 460 bp fragment containing
PestA2 is subject to regulation by H-NS. To confirm that this was
the case, the various pRW50 derivatives were used to transform
M182Dlac and M182DlacDhns cells. We then measured LacZ
activity, driven by PestA2, in the transformants. Consistent with
our expectations the data show that PestA2 is repressed 5-fold by
H-NS only in the context of the 460 bp DNA fragment (Fig. 4C).
Importantly, mutations in the CRP binding site abolish PestA2
activity in the absence of H-NS. Hence, the measured LacZ
expression must be driven by PestA2 rather than any spurious
promoters located within the estA2 gene. Taken together our
ChIP-seq and LacZ activity data show that H-NS prevents CRP
from activating PestA2.
The estA2 and estA1 promoters are differently regulated
by CRP but similarly regulated by H-NS
The estA1 regulatory region, located on plasmid p666, contains
a sequence similar to PestA2 (Fig. 5A). We expected that this
sequence would be the estA1 promoter (PestA1). To test this
expectation we created a 92 bp PestA1::lacZ fusion, equivalent to
the 93 bp PestA2::lacZ fusion described above, and mapped the 59
end of the resulting mRNA. As expected, the primer extension
product was 109 nt in length (Fig. 5B). Hence, PestA1 and PestA2
use equivalent TSSs. However, we were surprised that the
intensity of the PestA1 primer extension product increased in cells
lacking CRP (Fig. 5B). Closer examination of the alignment in
Fig. 5A shows that, whilst PestA1 and PestA2 are similar, there are
differences in the sequence and position of key promoter elements.
To try and understand which changes result in the aberrant
behaviour of PestA1 we made a set of hybrid promoters. The
hybrid constructs are derived from the CRP-activated estA2
promoter. In each hybrid, named PestA2.1 through PestA2.7, a
region of PestA2 was replaced with the equivalent region from
Table 1. Cont.
Peak Centrea Binding Site(s)b Gene(s)c K-12 Homologuesd
TGTGATTTGAATCACT
4508745 TGTGATATTTGTCACA (ETEC_4165)/ETEC_4164 (fdhD)/fdoG
4517442 CGTGATCGCTGTCCCA (ETEC_4173) (rhaA)
4564670 TGCGATCCGCCTCATA ETEC_4216/ETEC_4217 ptsA/frwC
4668870 TGTAACAGAGATCACA ETEC_4289/ETEC_4290 malE/malK
4725047 TGTGCGGATGATCACA n.a. n.a.
4731402 TGTGATCTTGCGCATA (ETEC_4365) (aphA)
4761367 CGTGATGGCTGTCACG ETEC_4389 fdhF
4846352 n.d. ETEC_4464 ETEC-specific
4848117 CGTGAGTTCTGTCACA n.a. n.a.
4863253 TTTGATCAACATCGCA (ETEC_4478) (ETEC-specific)
4873926 GGTGATCTATTTCACA ETEC_4486/ETEC_4487 aspA/fxsA
4930149 TGTGATGAACTTCAAA ETEC_4545/ETEC_4546 yjfY/rpsF
4940903 TGTGATCACTATCGCA ETEC_4557/ETEC_4558 ETEC-specific/ytfA
4993073 TGTGACTGGTATCTCG (ETEC_4604) (valS)
5002854 TGTAACCTTTGTCACA ETEC_4610/tRNA-Leu yjgB/tRNA-Leu
5030724 TGCGATGAATGTCACA ETEC_4633/ETEC_4634 gntP/uxuA
5129400 CGTACCGTCGGTCACA (ETEC_4736) (yjjI)
5129944 TGTGATGTATATCGAA ETEC_4736/ETEC_4737 yjjI/deoC
aChomosome coordinate of the ChIP-seq peak in H10407. Underlined text indicates that the ChIP-seq peak maps to sequence that is not conserved in E. coli K-12.
bCRP binding site sequence predicted by MEME. ‘‘n.d.’’ indicates that MEME did not detect a putative binding site.
cGenes in parentheses indicate that the ChIP-seq peak is located within that gene. Downstream genes are only listed if the annotated gene start is #300 bp
downstream of the CRP ChIP-seq peak. ‘‘n.a.’’ indicates that no genes starts are #300 bp from the CRP ChIP-seq peak.
dE. coli K-12 homologues are listed for the ETEC genes in the previous column. Genes in parentheses indicate that the ChIP-seq peak is located within that gene. ‘‘n.a.’’
indicates that no genes starts are #300 bp from the CRP ChIP-seq peak. ‘‘ETEC-specific’’ indicates that there is no K-12 homologue. Underlined genes have been
identified as CRP targets in a previous ChIP-chip study [15]. Bold genes are listed as CRP targets in the Ecocyc database.
doi:10.1371/journal.ppat.1004605.t001
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PestA1 (see underlined sequences in Fig. 5C). The ability of the
different hybrid promoters to drive lacZ expression, with and
without CRP, was then tested. The results are shown in Fig. 5D.
Note that, in Fig. 5D, the composition of each hybrid promoter is
indicated in the grid below the graph. For example, PestA2.1 is
derived from PestA2 but contains the PestA1 CRP site. As
expected, both PestA1 and PestA2 were able to drive lacZ
expression but CRP had opposite effects. Moreover, maximal
expression from PestA1 was 3-fold lower than from PestA2. Only
PestA2.3 and PestA2.5, which both carried the same changes in
the promoter -35 element, exhibited a reversed dependence on
CRP. Hence, the PestA1 -35 element must be responsible for the
altered CRP dependence. All other hybrid promoters exhibited an
overall reduction in activity compared to the parent PestA2
construct. We conclude that this combination of changes results in
the lower activity of PestA1. Note that both PestA1 and PestA2
were bound by H-NS in our ChIP-seq analysis (Fig. 2C). We
reasoned that cloning PestA1, with flanking DNA, would reveal H-
NS mediated repression. We generated a derivative of the
PestA1::lacZ fusion where the downstream boundary was extend-
ed to include the entire estA1 gene (S2B Fig., Fig. 5Ei). As
expected, transcription from PestA1 was repressed by H-NS in the
presence of downstream DNA (Fig. 5Eii).
The eltAB operon is indirectly repressed by CRP and
directly repressed by H-NS
We next turned our attention to the LT toxin promoter (PeltAB)
[26,27]. Previously, Bodero and Munson [27] showed that
transcription from this promoter was repressed by CRP. A
mechanism for repression was proposed whereby CRP acted
directly by binding three DNA targets overlapping PeltAB [27].
Even so, no CRP binding at PeltAB was identified by our ChIP-
seq analysis (Fig. 6A). It is possible that this is because H-NS also
excludes CRP from this locus (Fig. 6A). However, we also failed to
identify CRP targets at PeltAB in our bioinformatic screen, even
below the stringent cut-off (Fig. 2, S1 Table). In retrospect, this
appears to be because all of three PeltAB CRP binding sites
contain at least 4 mismatches to the consensus for CRP binding
(Fig. 6A). Hence, we measured the affinity of CRP for PeltAB
using EMSA assays. In parallel, we tested CRP binding to PestA2
as a control. As expected, CRP bound tightly to PestA2 at low
concentrations (Fig. 6B, lanes 1–6). At high CRP concentrations
further non-specific binding was observed (evidenced by a
conspicuous ‘‘smear’’ in DNA migration in lane 7). In the
equivalent experiment, with PeltAB, no specific binding of CRP
was observed (lanes 8–13). However, non-specific CRP binding
was again detectable at high protein concentrations (lane 14).
Hence, CRP does not bind specifically to PeltAB. We hypothesised
that previously observed changes in PeltAB activity, in cells lacking
CRP, may occur indirectly. To test this, we cloned a 359 bp DNA
fragment, containing PeltAB, into our pRW50 lacZ expression
system. We also made a truncated 118 bp derivative of this
construct where two of the three putative CRP targets were
removed. A derivative of the truncated 118 bp construct, where
the remaining CRP site was completely ablated by point
mutations, was also made. The DNA sequences of the different
constructs are shown in S2C Fig. They are illustrated graphically
in Fig. 6Ci. Consistent with previous measurements, we found that
transcription from PeltAB increased 2.5 fold in the absence of
CRP. However, the response of PeltAB was identical when the
CRP binding sites were removed (Fig. 6Cii). Hence, although
CRP represses transcription from PeltAB, this must occur
indirectly.
Given the configuration of H-NS binding at the eltAB locus
(Fig. 6A) we reasoned that PeltAB would be repressed by H-NS in
the presence of sufficient flanking DNA. As we had done
previously for PestA1 and PestA2, we compared the binding of
H-NS to PeltAB in the presence and absence of the downstream
flanking sequence. The different DNA constructs are illustrated in
Fig. 7A and results of ChIP experiments to measure H-NS binding
are shown in Fig. 7B. As predicted, enrichment of PeltAB, in
immunoprecipitations with anti-H-NS, was only observed in the
presence of downstream DNA. Importantly, this enrichment was
specific to PeltAB and not observed for the control locus yabN.
Corresponding LacZ activities, for the different DNA constructs,
measured in M182 or the Dhns derivative, are shown in Fig. 7C.
Incorporation of flanking DNA downstream of PeltAB resulted in
a 15-fold reduction in LacZ activity that was largely relieved in the
absence of H-NS.
CRP and H-NS allow the estA1, estA2 and eltAB promoters
to respond to glucose and salt
Given the established regulatory connections between CRP and
glucose, and between H-NS and salt, we next measured changes in
the activity of PestA1, PestA2 and PeltAB in response to glucose
and salt. A complete description of assay conditions is provided in
the Materials and Methods section. Briefly, to establish the range
Fig. 2. Unoccupied CRP sites on p666 and p948 align with H-NS
bound regions. A) A histogram showing the number of putative CRP
binding sites in each of 7 discrete bins. Each bin is delineated by the
‘‘score’’ of the putative CRP site. A high score indicates a better match
to the Position Weight Matrix that represents the consensus for CRP
binding. B) The graph illustrates binding of CRP to a target from each of
the bins shown in Panel A. CRP was used at concentrations of 0, 175,
350 or 700 nM. C) ChIP-seq data for CRP and H-NS binding at five
regions of plasmids p666 and p948 that contain unoccupied CRP
targets bound by CRP in vitro. The CRP and H-NS binding profiles are
plots of sequence read counts at each position of the genome on both
the top (above the central line) and bottom (below the central line)
strand of the DNA. The y-axis scale is the same in each panel. The scale
for H-NS binding is 1,785 reads on each strand and for CRP binding is
14,000 reads on each strand.
doi:10.1371/journal.ppat.1004605.g002
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of conditions across which the promoters were able to respond, we
examined the effect of titrating glucose or salt into the growth
medium individually. In all experiments, we used the promoter::
lacZ fusions that included downstream flanking DNA. This was to
ensure that signals sensed by both CRP and H-NS could
be integrated. As expected, the activity of PestA1 was low.
Consequently, the effects of glucose and salt were negligible (S4A
Fig.). Conversely, the activity of PestA2 was sensitive to both
glucose and salt (S4B Fig.). Thus, lacZ expression driven by PestA2
was repressed by glucose (orange line) and enhanced by salt (green
line). As expected, PeltAB activity increased in the presence of
both salt and glucose, but induction by salt was more prominent
(S4C Fig.). We hypothesised that, for PestA2, the inhibitory effect
of glucose should override the stimulatory effect of salt. Our
reasoning was that, although H-NS can repress PestA2, the
promoter is ultimately dependent on CRP for activity. Hence, we
examined the effect of adding salt and glucose, to cells carrying the
PestA2::lacZ fusion, separately and in combination (Fig. 8A). As
predicted, the inhibitory effect of glucose was dominant (Fig. 8Ai)
and was still observed in the absence of H-NS (Fig. 8Aii).
Conversely, the stimulatory effect of salt required H-NS (compare
green bars in Fig. 8). Importantly, in a separate experiment, we
also showed that the effect of glucose on PestA2 activity requires
that the CRP site is intact (S4D Fig.). The combined effect of salt
and glucose on PeltAB was more difficult to predict because CRP
acts via an undefined, and indirect, mechanism. The result of the
analysis (Fig. 8B) shows that the stimulatory effects of salt and
glucose on transcription from PeltAB are not additive. Moreover,
the stimulatory effect of glucose requires H-NS.
The response of PeltAB and PestA2 to CRP and H-NS is
conserved in other ETEC isolates and during host cell
attachment
Examination of all sequenced ETEC genomes reveals slight
variations in the sequence of the eltAB and estA2 promoter
sequences (recall that ETEC H10407 is somewhat anomalous in
also encoding estA1). Thus, we next sought to understand if our
model for regulation of LT and ST expression was broadly
applicable. We focused our efforts on ETEC E24377A since i) the
genome has been sequenced and ii) a vast array of independently
generated transcriptomic data are available for this organism
Fig. 3. The estA2 promoter is activated by a Class I CRP dependent mechanism. A) Sequence of the estA2 gene regulatory region. The CRP
binding site is shown in orange, the UP element is blue and the promoter -10 and -35 elements are shown in purple. The different promoter positions
are numbered relative to the transcription start site (+1). B) Location of the PestA2 transcription start site. The gel shows the product of an mRNA
primer extension analysis to determine the estA2 transcription start site (Lane 5). The gel was calibrated using arbitrary size standards (A, C, G and T in
Lanes 1–4). C) Binding of CRP to PestA2. The panel shows the result of a DNAse I footprint to monitor binding of CRP to the 93 bp PestA2 DNA
fragment. The gel is calibrated with a Maxim-Gilbert DNA sequencing reaction. CRP was added at concentrations of 0.35–2.1 mM. D) CRP is required
for transcription from PestA2 in vivo. The panel shows a cartoon representation of the 93 bp PestA2::lacZ fusion and a bar chart illustrates LacZ activity
in lysates of cells carrying this fusion. Assays were done in LB medium. E) i) Stimulation of PestA2 by CRP in vitro. The figure shows the results of an in
vitro transcription reaction. The 112 nt transcript initiates from PestA2 and the 108 nt RNAI transcript is an internal control. CRP was added at a
concentration of 350 nM and RNA polymerase was added at a concentration of 400 nM. ii) quantification of band intensities from the in vitro
transcription analysis.
doi:10.1371/journal.ppat.1004605.g003
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[28,29]. Using ETEC E24377A DNA as a template, we generated
a 460 bp PestA2, and 1126 bp PeltAB DNA fragment. The
sequences are shown in S2D Fig. The DNA fragments were cloned
into pRW50 and the ability of the promoters to drive lacZ
expression in response to CRP and H-NS was measured. As
expected, transcription from PestA2 was repressed by H-NS and
activated by CRP whilst PeltAB was repressed by H-NS (Fig. 9A).
We observed no effect of CRP on transcription from PeltAB in the
context of the 1126 bp ETEC E24377A fragment. This is not
unexpected because CRP acts indirectly and these indirect CRP
effects have only previously been observed in the context of short
DNA fragments containing PeltAB that are not subject to direct
repression by H-NS. We note that Sahl and Rasko previously
examined the global transcriptome response of E24377A to
glucose levels and bile salts [28]. In exact agreement with our
model for toxin regulation, and the data in Fig. 9A, this study
confirmed that i) salt induced expression of both toxins and ii)
glucose inhibited expression of estA2 [28]. Fortuitously, changes in
the ETEC E24377A transcriptome, prompted by ETEC attach-
ment to human gut epithelial cells, have also been quantified
comprehensively [29]. Briefly, in these experiments, ETEC were
added to sets of Caco-2 intestinal epithelial cell tissue cultures.
Over a time course, ETEC that had adhered to host cells were
separated from non-adhered ETEC. The transcriptomes of
adhered and non-adhered ETEC were then compared. By mining
these data, we next sought to determine if our model was
consistent with observed changes in the transcription of crp, hns,
eltA and estA during host cell attachment. Briefly, our data predict
that changes in estA expression should be directly correlated to
changes in the level of CRP and inversely correlated with changes
in levels of H-NS. Conversely, levels of eltA expression should be
inversely correlated with levels of H-NS. The result of the analysis
is illustrated in Fig. 9B. The data show that the relative levels of
crp transcription in attached and unattached cells are similar
(orange line). However, levels of hns transcription change
dramatically (green line) 60 minutes after host cell attachment.
As predicted by our model, levels of estA2 and eltA transcription
(dashed lines) inversely track changes hns transcript levels. When
undertaking this analysis we noticed that, although there was little
change in the relative level of crp mRNA between attached and
unattached ETEC cells, the absolute level of crp mRNA did
fluctuate across the time course of the experiment and between
biological replicates. Strikingly, when these absolute mRNA levels
are compared there is a clear linear relationship between crp and
estA2 expression (Fig. 9C). Note that in Fig. 9C the absolute level
of hns mRNA has been added in parenthesis for each data point.
Remarkably, the only two outlying data points in this plot
correspond to the two samples with increased hns expression. We
conclude that regulation of estA2 and eltA by CRP and H-NS is
important during the attachment of ETEC to human intestinal
epithelial cells, and that the regulatory control of ETEC toxins is
conserved across different strains.
Disrupting the regulatory switch attenuates ETEC
virulence
Taken together, our data suggest that CRP and H-NS form a
regulatory switch that controls ETEC toxicity. We next sought to
examine the effect of disabling the switch on virulence. This is not
straightforward because no animal model faithfully mimics the
disease caused by ETEC in humans. However, intranasal mouse
models have been used as a proxy for measuring E. coli
pathogenicity [30]. Importantly, pathogenic E. coli cause more
severe disease in this model than non-pathogenic strains [30].
Furthermore, ETEC strains lacking genes encoding toxins and
known colonisation factors are less virulent in this model [31]. We
opted to disrupt the regulatory switch by removing the crp rather
than the hns gene. This was a deliberate decision since E. coli
strains lacking hns are severely attenuated for growth in laboratory
conditions. Conversely, the crp null derivative of ETEC H10407
was only mildly compromised for growth in liquid culture. Hence,
we compared pathogenicity of ETEC H10407, and the crp
derivative, using the intranasal mouse model [30]. Note that the
outcome of this experiment is difficult to predict since the effects of
CRP on pathogenicity likely go far beyond the control of toxin
expression. However, it is reasonable to assume that ETEC
virulence should differ in cells lacking crp. The median survival of
mice challenged with wild type ETEC was 53 hours and the
Fig. 4. The estA2 promoter is repressed by H-NS. A) The panel shows different PestA2::lacZ fusions. The lacZ gene is shown as a red arrow and
the estA2 gene is shown as a blue arrow. PestA2 is illustrated using a bent arrow and the CRP binding site is shown as an orange box. B) H-NS binds to
PestA2 only in the presence of flanking DNA. ChIP-PCR was used to measure binding of H-NS to the different PestA2 derivatives cloned in pRW50. PCR
products were generated using primers that could detect PestA2 in the context of both the 93 bp fragment and the longer 460 bp fragment. C) The
values are b-galactsidase activity values for lysates of M182, or M182Dhns, carrying the different PestA2 derivatives. Assays were done in LB medium.
doi:10.1371/journal.ppat.1004605.g004
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mortality rate was 100%. Conversely, the median survival of mice
challenged with Dcrp ETEC was 72 h and 20% of the mice
survived (Fig. 9D). Thus, whilst the full extent to which CRP co-
ordinates the ETEC virulence programme remains to be
determined, CRP is clearly central to the pathogenic response.
Discussion
A complex hierarchy of salt and glucose-dependent
regulation controls toxin expression
We propose that toxin expression in ETEC can be controlled by
osmo-metabolic flux. This is relevant to conditions in the small
intestine (osmolarity equivalent to 300 mM NaCl) disease symp-
toms (the extrusion of cations and cAMP into the gut lumen) and
treatment (the ingestion of solutions containing glucose and salt)
[7–11,32]. A molecular model, describing how the different signals
are integrated, is illustrated in Fig. 10. Two gene regulatory
proteins, CRP and H-NS, are central to our model. Hence, H-NS
directly represses the expression of eltAB, estA1 and estA2
(pathways ‘‘a’’ and ‘‘b’’ in Fig. 10). For estA2 and eltAB this
repression can be relieved, in an H-NS dependent manner, by
increased osmolarity. At PestA2 CRP directly activates transcrip-
tion by a Class I mechanism (pathway ‘‘c’’). H-NS can interfere
with this process by competing with CRP for binding at PestA2
(pathway ‘‘d’’). Finally, CRP can indirectly repress expression of
eltAB via an unknown pathway that is influenced by H-NS (‘‘e’’).
Both pathways ‘‘c’’ and ‘‘e’’ are sensitive to glucose availability
because of their dependence on CRP. We speculate that pathway
Fig. 5. Comparison of PestA1 and PestA2 reveals differential activity and regulation by CRP. A) Comparison of PestA1 and PestA2. The
panel shows the DNA sequences of PestA1 and PestA2. Bases that are identical are highlighted by a solid vertical line. The CRP sites are shown in
orange, the UP element in blue and the core promoter elements in purple. The sequences are numbered with respect to the transcription start site (+
1). B) Location of the PestA1 transcription start site. The gel shows products from an mRNA primer extension analysis (Lanes 5 and 6). The gel was
calibrated using arbitrary size standards (A, C, G and T in Lanes 1–4). C) Sequences of hybrid estA promoters. The sequences labelled estA2.1 through
estA2.7 are derivatives of the 93 bp PestA2 DNA fragment where different sequence elements have been replaced with the equivalent sequence from
PestA1. D) The bar chart shows b-galactosidase activity measurements for lysates obtained from cultures of M182, or the Dcrp derivative, containing
the indicated hybrid promoter fragment was fused to lacZ. E) The panel shows different PestA1::lacZ fusions. The lacZ gene is shown as a red arrow
and the estA1 gene is shown as a blue arrow. PestA1 is illustrated using a bent arrow and the CRP binding site is shown as an orange box. Assays were
done in LB medium.
doi:10.1371/journal.ppat.1004605.g005
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‘‘e’’ may include H-NS since the effects of salt and sugar on eltAB
expression were epistatic (Fig. 8). Our model for H-NS repression
of eltAB is consistent with previous work [26]. However, our
conclusion that eltAB is indirectly repressed by CRP disagrees with
a previous study [27]. Even so, we were able to faithfully
reproduce most of the observations previously described by
Bodero and Munson [27]. We note that Bodero and Munson
previously suggested that CRP may bind targets at PeltAB with a
7, rather than 6, base pair spacer between the two CRP half sites.
Such CRP targets have never been described amongst hundreds of
known CRP regulated promoters. Furthermore, we found no such
CRP sites in our ChIP-seq analysis. Given that these DNA
sequences can be deleted, without negating the effect of CRP on
PeltAB activity, the regulatory effect of CRP must be indirect.
Oral Rehydration Therapy is likely to impact on toxin
expression
Our model for regulation of ST and LT expression is pertinent
to both ETEC mediated disease and its treatment. ST and LT
trigger the extrusion of H2O, cations, and cAMP (the cofactor for
CRP) from the small intestine into the gut lumen [4–9].
Furthermore, solutions of salt and glucose are consumed by
patients to reverse this process [10,11]. We speculate that, during
infection, extrusion of electrolytes and cAMP into the gut lumen
could create a positive feedback loop to drive toxin expression.
Importantly, our model also suggests that ORT may provide
benefits beyond stimulating rehydration of the patient. The
concentration of glucose used in ORT is ,10-fold higher than
is required to repress estA2 expression. Hence, even if 90% of
glucose present in ORT solutions is absorbed before reaching the
site of infection, sufficient glucose should be present to down
regulate toxin expression. Furthermore, even though salt is able to
induce expression of estA2 and eltAB, the effect is only observed at
concentrations far higher than those found in ORT solutions.
Differential regulation of estA1 and estA2 by CRP
Our observation that estA1 and estA2 are oppositely regulated
by CRP is intriguing given the similarities between the promoter
sequences of these genes. Differential regulation is dependent on
the promoter -35 element (Fig. 5). At Class I CRP regulated
promoters an aCTD protomer sits between CRP and domain 4 of
the RNA polymerase s subunit, which is bound to the promoter -
35 element [12]. Thus, one possible explanation is that changes in
the -35 element result in subtle repositioning of s. This could
result in unproductive interactions between aCTD and s when
CRP is present.
Fig. 6. The eltAB promoter is indirectly repressed by CRP. A) The Panel shows ChIP-seq data for CRP and H-NS binding at the eltAB locus. The
sequence of 3 putative CRP binding sites proposed by Bodero and Munson (2009) are shown. The CRP and H-NS binding profiles are plots of
sequence read counts at each position of the genome on both the top (above the central line) and bottom (below the central line) strand of the DNA.
The y-axis scale for H-NS binding is 1,785 reads on each strand and for CRP binding is 14,000 reads on each strand. B) Results of an Electorphoretic
Mobility Shift Assay to measure binding of CRP to the 93 bp PestA2 fragment (Lanes 1–7) or the 359 bp PeltAB fragment (Lanes 8–14). Specific and
non-specific binding of CRP is indicated to the left and right of the gel. CRP was added at a concentration of 0.2–7.0 mM. C) Panel (i) shows different
PeltAB::lacZ fusions. The lacZ gene is shown as a red arrow and the eltAB operon is shown in purple. PeltAB is illustrated using a bent arrow and the
putative CRP binding sites are shown as open orange boxes. In panel (ii) the values are b-galactsidase activity measurements taken in M182 or the
Dcrp derivative. Assays were done in LB medium.
doi:10.1371/journal.ppat.1004605.g006
Fig. 7. The eltAB promoter is directly repressed by H-NS. A) The panel shows two PeltAB::lacZ fusions. B) The results of a ChIP-PCR analysis
used to measure binding of H-NS to the two different PeltAB derivatives shown in Panel A. C) The values are b-galactsidase activity measurements for
lysates of M182, or the Dhns derivative, carrying the different PestA2::lacZ fusions. Assays were done in LB medium.
doi:10.1371/journal.ppat.1004605.g007
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H-NS prevents CRP regulation of select target genes
Our data indicate that several strong CRP binding sites in the
H10407 genome are occluded by H-NS. This strongly suggests
that the CRP regulon has evolved to incorporate additional
environmental signals through the action of H-NS. The repressive
effect of H-NS on transcription has been widely described [23]. H-
NS represses transcription predominantly by occluding the
binding of RNAP or by trapping RNAP at promoters [20].
Recently, it was shown that H-NS occludes many binding sites for
the CRP homologue, FNR, in E. coli [21]. Thus, occlusion of
transcription factor binding sites appears to be a major function of
H-NS, especially for CRP family proteins. Note that, in order to
exclude CRP from target promoters, sites of H-NS nucleation and
CRP binding need not overlap precisely. For example, at both
estA1 and estA2, maximal H-NS binding is observed within the
coding sequence of the gene (Fig. 2C). Despite this, H-NS
oligomerisation across adjacent DNA is sufficient to prevent
CRP binding.
Conclusions
In summary, our model provides a framework for better
understanding ETEC mediated disease and its treatment. More-
over, our catalogue of CRP and H-NS binding targets provide a
useful community resource for further studies of all E. coli strains.
In particular, our ChIP-seq data for CRP report .50 targets not
identified previously in E. coli K-12 and 8 ETEC-specific targets.
Finally, our data show how very small changes in the organisation
Fig. 8. H-NS and CRP integrate signals of osmolarity and
metabolism to control expression of LT and ST. The figure shows
b-galactosidase activity measurements for lysates obtained from
cultures of M182 (i) or the Dhns derivative (ii) containing A) PestA2 or
B) PeltAB fused to lacZ in plasmid pRW50. Cultures were grown in the
presence and absence of 2% glucose and/or salt (60 mM NaCl and
20 mM KCl). Assays were done in M9 minimal medium so that the
glucose and salt concentrations could be more accurately controlled.
doi:10.1371/journal.ppat.1004605.g008
Fig. 9. Modulation of estA2 and eltA transcription during attachment of ETEC E24377A to gut epithelial cells. A) The figure shows b-
galactosidase activity measurements for lysates obtained from cultures of M182 or the Dhns and Dcrp derivatives containing PestA2 (460 bp
fragment) or PeltAB (1126 bp fragment) from ETEC 24377A fused to lacZ in plasmid pRW50. B) The panel shows log2 fold changes in the transcription
of crp, hns, eltA and estA in ETEC E24377A cells over a two hour incubation with a Caco-2 intestinal epithelial cell culture (29). The log2 values
represent the fold change in transcription between ETEC cells attached and unattached to Caco-2 cells at each time point. C) The panel shows a
scatter plot of absolute crp and estA2 mRNA levels in ETEC E24377A attached to Caco-2 intestinal epithelial cells. Each data point represents a
different biological replicate. For each data point the absolute level of hns mRNA is shown in parenthesis. D) The panel shows the survival rate of
BALB/C mice (n = 30) after intranasal inoculation with wild type ETEC H10407 or the Dcrp derivative.
doi:10.1371/journal.ppat.1004605.g009
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of gene regulatory regions can have major effects on gene
expression, such that transcription responds differently to the same
environmental cues.
Materials and Methods
Strains, plasmids and oligonucleotides
ETEC strain H10407 is described by Crossman et al. [1]. The
C-terminal crp-36FLAG tag was introduced into the H10407
chromosome using the recombineering method of Stringer et al.
[33]. Wild type E. coli K-12 strains JCB387 and M182 have been
described previously [34,35]. The Dhns M182 derivative was
generated by P1 transduction of hns::kan from E. coli K12
derivative YN3144 (a gift from Ding Jin). Plasmids pRW50 and
pSR are described by Lodge et al. [36] and Kolb et al. [37]. More
detailed descriptions of strains and plasmids, along with the
sequences of oligonucleotides, are provided in S2 Table.
ChIP-seq
Cultures were grown to mid-log phase in M9 minimal medium
with 1% (w/v) fructose at 37uC. Targeted ChIP experiments
(Fig. 4 and 6) were done exactly as described by Singh and
Grainger [38] using PestA2 or PeltAB fragments cloned in pRW50
carried in strain M182. The ChIP-seq was done as described
extensively by Singh et al. [25] using strain H10407. Briefly, H-NS
and CRP-36FLAG were immunoprecipitated using protein A
sepharose (GE Healthcare) in combination with 2 mL of anti-H-
NS or 2 ml of anti-FLAG respectively. After immunoprecipitation
and washing, beads were resupended in 100 mL 16 Quick
Blunting Buffer (NEB) with dNTPs (as specified by the manufac-
turer) and 2 mL Quick Blunting Enzyme Mix, and incubated for
30 minutes at 24uC with gentle mixing. After being collected by
centrifugation, the beads were again washed and the associated
DNA was A-tailed by resuspension of beads in 100 mL 16NEB
buffer #2 supplemented with 2 mM dATP and 10 units of
Klenow Fragment (39R59 exo-; NEB). Following incubation for
30 minutes at 37uC, with gentle mixing, the beads were again
collected and washed. Illumina adapters (1 ml NEXTflex ChIP-seq
barcoded adapters; BioO Scientific) were added to beads
resuspended in 100 mL 16 Quick Ligation reaction buffer and
4 mL Quick T4 DNA Ligase (NEB), and incubated for 15 minutes
at 24uC with gentle mixing. After washing the beads, the DNA was
the eluted into a fresh tube by addition of 100 mL ChIP elution
buffer (50 mM Tris–HCl, pH 7.5, 10 mM EDTA, 1% SDS) and
incubation at 65uC for 10 minutes. The eluate was collected by
centrifugation for one minute at 4000 rpm. Crosslinks were
reversed by incubation for 10 minutes at 100uC. Samples were
purified by phenol extraction and precipitated with ethanol, 40 mg
glycogen and 8.3 mM sodium acetate. DNA was pelleted for
15 minutes at 4uC at top speed in a microcentrifuge, washed with
70% ethanol, dried and resuspended in 11 mL H2O. After
quantification by PCR each library was amplified, purified and
resuspended in 20 mL H2O. Libraries were the sequenced using a
HiSeq 2000 sequencer (Illumina; University at Buffalo Next
Generation Sequencing Core Facility). Sequence reads were
aligned to non-repetitive sequences in the E. coli H10407 genome
using CLC Genomics Workbench and overall coverage was
determined using custom Python scripts. Sequence reads have
been submitted to the EBI ArrayExpress database and can be
accessed using accession number E-MTAB-2917.
Bioinformatics
ChIP-seq peaks were identified as described previously [25].
We refer to these peaks as ‘‘high stringency’’ peaks. A second
round of peak calling was performed in which the sequence read
threshold values (i.e. the minimum number of sequence reads at a
given genomic position that is required for a peak to be called)
was reduced by 20%. We refer to these peaks as ‘‘low stringency’’
peaks. MEME [39] was used to identify enriched sequence motifs
in the sequences from 50 bp upstream to 50 bp downstream of
the high stringency peak centres. Thus, we identified a motif
closely resembling the known CRP consensus site in many of the
regions surrounding high stringency ChIP-seq peaks. These CRP
site sequences are included in Table 1. Those high stringency
peaks for which MEME did not identify a motif were used for a
second round of analysis using MEME. This also identified a
motif closely resembling the known CRP consensus site. These
CRP site sequences are also included in Table 1. We used
MEME to identify enriched sequence motifs in the low stringency
peak list. This also identified a motif closely resembling the
known CRP consensus site. These CRP site sequences are also
included in Table 1. ‘‘High-confidence’’ ChIP-seq peaks listed in
Table 1 include all the high stringency peaks but only those low
stringency peaks for which we identified a motif using MEME. A
complete list of all peaks, including low stringency peaks for
which a motif was not identified by MEME, is provided in S3
Table. In order to assess the location of CRP sites with respect to
TSSs we used the targets listed in Table 1. For each target the
predicted sequence from MEME was used in a BLAST search
against the E. coli K-12 MG1655 genome. All but 11 CRP sites
in ETEC had a single perfect match in the E. coli K-12
chromosome. For each perfect match the distance from the
centre of the CRP site to all transcription start sites was
calculated. Transcription start site coordinates are from Kim et
al. [40] and Cho et al. [41]. Distances between 2200 and +100
were selected and all other distances were discarded. Distances
were then grouped in bins of 5 bp each and the most common
distance bins were identified. Note that, because the position of
the CRP site was transposed onto the E. coli K-12 genome, the
distance between CRP sites and TSSs
The PWM describing CRP binding sites was generated using
the PREDetector software package and our previous list of 68
CRP binding sites in the E. coli K-12 genome [15,42]. Subsequent
bioinformatic screens of plasmids p666 and p948 were done by
importing the relevant genbank files into PREDetector and
running a binding site search with a cut-off of 7 using settings
that did not exclude CRP sites within genes. The ‘‘score’’ for each
site predicted by PREDetector increases if a closer match to the
PWM is found. To generate the chromosome and plasmid maps
shown in Fig. 1 we used DNA plotter software [43].
Data shown in Fig. 9B–C were extracted from the publically
available datasets of Kansal et al. [29] that measure changes in the
Fig. 10. An osmo-metabolic gene regulatory circuit comprised
of CRP and H-NS controls expression of LT and ST. The diagram
illustrates the regulatory effects of salt, cAMP and glucose on
transcription from the various ST and LT promoter regions.
doi:10.1371/journal.ppat.1004605.g010
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ETEC E24377A transcriptome upon contact with Caco-2
intestinal epithelial cells. The data are hosted under the GEO
accession code GSE40427. For each assay condition (planktonic
and attached ETEC cells) we extracted the signal intensity for
microarray probe sets A1527 (crp), UTI189_C1433 (hns), D4754
(eltA) and D4048 (estA). The average signal intensity was
calculated and the fold change in transcription in attached
compared to planctonic ETEC cells was determined for each time
point. The data in Fig. 9C show a comparison of absolute signal
intensities for probe sets A1527 (crp) and D4048 (estA) compared
for each of the two replicates obtained at 30, 60 or 120 minutes
after attachment to host cells. Signal intensities obtained after
30 minutes growth in LB medium (three replicates) are also
included in this analysis.
Proteins
The CRP and s70 purification was done exactly as described
previously [44,45]. RNA polymerase core enzyme was purchased
from Epicenter. RNA polymerase holoenzyme was generated by
incubating the core enzyme with an equimolar concentration of
s70 at room temperature for 20 minutes prior to use. H-NS was
overexpressed in T7 express cells from plasmid pJ414hns. After
overexpressing H-NS, cells were collected from the culture by
centrifugation and resuspended in buffer A (20 mM Tris-HCl
pH 7.2, 1 mM EDTA and 10% (v/v) glycerol) containing
100 mg/ml PMSF. Cells were lysed by sonication and the sample
was cleared by centrifugation. The supernatent was loaded directly
onto a Heparin column (Amersham) pre-equilibrated with buffer
A. A linear NaCl gradient was applied and H-NS was found to
elute at approximately 500 mM NaCl. The peak fractions were
pooled and diluted 3-fold with buffer A. The sample was then
loaded onto an S-FF column (Amersham) pre-equilibrated with
Buffer A. A NaCl gradient was applied and H-NS eluted at
approximately 550 mM NaCl. The H-NS containing fractions
were then dialysed against a buffer containing 20 mM Tris HCl
(pH 7.2), 300 mM KCl and 10% Glycerol (v/v)for storage at 2
80uC.
DNAse I footprinting and Electrophoretic Mobility Shift
Assays
DNA fragments for DNAse I footprinting or EMSA assays were
excised from pSR by sequential digestion with HindIII and then
AatII. After digestion, fragments were labelled at the HindIII end
using [c-32P]-ATP and T4 polynucleotide kinase. DNAse I
footprints and EMSA experiments were then done as described
by Grainger et al. [45] except that cAMP was added to reactions
at a concentration of 0.2 mM. Radio-labelled DNA fragments
were used at a final concentration of ,10 nM. Note that all in
vitro DNA binding reactions contained a vast excess
(12.5 mg ml21) of Herring sperm DNA as a non-specific compet-
itor. Footprints were analysed on a 6% DNA sequencing gel
(molecular dynamics). The results of all footprints and EMSA
experiments were visualized using a Fuji phosphor screen and Bio-
Rad Molecular Imager FX.
Primer extension assays
Transcript start sites were mapped by primer extension, as
described in Lloyd et al. [46] using RNA purified from strains
carrying the 92 bp PestA1 or 93 bp PestA2 fragment cloned in
pRW50. The 59 end-labelled primer D49724, which anneals
downstream of the HindIII site in pRW50, was used in all
experiments. Primer extension products were analysed on
denaturing 6% polyacrylamide gels, calibrated with size standards,
and visualized using a Fuji phosphor screen and Bio-Rad
Molecular Imager FX.
In vitro transcription assays
The in vitro transcription experiments were performed as
described previously Savery et al. [35] using the system of Kolb
et al. [38]. A Qiagen maxiprep kit was used to purify supercoiled
pSR plasmid carrying the different promoter inserts. This template
(,16 mg ml21) was pre-incubated with purified CRP in buffer
containing 0.2 mM cAMP, 20 mM Tris pH 7.9, 5 mM MgCl2,
500 mM DTT, 50 mM KCl, 100 mg ml21 BSA, 200 mM ATP,
200 mM GTP, 200 mM CTP, 10 mM UTP with 5 mCi [a-32P]-
UTP. The reaction was started by adding purified E. coli
RNA polymerase. Labelled RNA products were analysed on a
denaturing polyacrylamide gel.
b-galactosidase assays and addition of glucose and salt
to growth medium
b-Galactosidase assays were done using the protocol of Miller
[47]. All assay values are the mean of three independent
experiments with a standard deviation ,10% of the mean. Cells
were grown aerobically at 37uC to mid-log phase in LB medium
unless stated otherwise. For all experiments investigating the
effects of glucose and salt M9 minimal medium was used so that
the glucose and salt concentrations could be controlled more
accurately. The amount of glucose is shown as percentage w/v.
The addition of ‘‘salt’’ refers to a 3:1 molar ration of NaCl to KCl.
We have arbitrarily described 30 mM NaCl and 10 mM KCl as
being a ‘‘1%’’ salt solution.
Intranasal mouse infection model assays
Strains of ETEC were grown in Luria Broth (LB) to an OD600
of 1.0. Groups of 10 mice (8–10 week old BALB/c) were infected
intranasally with approximately 16109 colony forming units of
bacteria in 100 ml of inoculums according to Byrd et al. [30]. Mice
were monitored daily for 6 days post-infection for weight and
morbidity.
Ethics statement
The protocol 12-02-015IBT ‘‘Oral Immunization of Mice with
Enterotoxigenic: E coli (ETEC)’’ has been approved by the Noble
Life Sciences IACUC committee. All animal care and use
procedures adhere to the guidelines set by the Public Health
Service Policy, U.S. Dept. of Agriculture (USDA) and the Guide
for the Care and Use of Laboratory Animals of the National
Institutes of Health.
Supporting Information
S1 Fig Binding of CRP to predicted targets in vitro. A)
The data show binding of CRP to a target from each of the bins
shown in Fig. 2. B) CRP binding to remaining targets scoring
.10. CRP was used at concentrations of 0, 175, 350 or 700 nM.
The ‘‘score’’ describes how well the predicted target matches the
PWM.
(PDF)
S2 Fig Promoter DNA fragments used in this work. A)
ETEC H10407 PestA2 containing DNA fragments. B) ETEC
H10407 derived DNA fragments containing PestA1. C) ETEC
H10407 PeltAB containing sequences. D) DNA fragments
containing sequences upstream of the estA2 and eltAB genes of
ETEC E24377A.
(PDF)
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S3 Fig A) Mutations in PestA2 UP-element alter the
migration of the promoter DNA on an agarose gel. The
DNA sequences used are shown in part (i) and the mobility of the
fragments, on an agarose gel, are shown in part (ii). Note that each
sample has been loaded in duplicate. B) Mutating the UP-element
renders PestA2 uninducible by CRP. Part (i) shows LacZ activity
data for the different promoter fragments cloned in pRW50. The
pRW50 derivatives were used to transform M182 or the Dcrp
derivative. Part (ii) shows the result of in vitro transcription assays
using the different promoter fragments, cloned in pSR, as a
template.
(PDF)
S4 Fig Activity of different promoter::lacZ fusions in
the presence of increasing glucose and salt concentra-
tions. The figure shows b-galactosidase activity measurements for
lysates obtained from cultures of M182 carrying the A) estA1 B)
estA2 or C) eltAB promoters cloned in pRW50. Panel D) shows b-
galactosidase activity values for lysates of M182 and M182Dhns
cells, carrying the estA2 promoter, or a derivative lacking the CRP
site, cloned in pRW50. Cells were grown in the presence or
absence of 2% glucose. Assays were done in M9 minimal medium
so that the glucose and salt concentrations could be more
accurately controlled.
(PDF)
S1 Table Putative CRP binding targets on ETEC
plasmids p948 and p666 identified by PREDetector.
(DOCX)
S2 Table Strains, plasmids and oligonucleotides.
(DOCX)
S3 Table All CRP binding sites on the ETEC H10407
chromosome identified by ChIP-seq.
(DOCX)
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